Anti-proliferative effect of peroxisome proliferator-activated receptor γ agonists on human malignant melanoma cells in vitro

Anti-Cancer Drugs

Volumn 17, Issue 3, 2006, Pages 325-332

  Freudlsperger, Christian ^a   Moll, Ingrid ^a   Schumacher, Udo ^a   Thies, Anka ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Apoptosis; Cell proliferation; Glitazones; Malignant melanoma; Peroxisome proliferator activated receptor ; Thiazolidinediones

Indexed keywords

CIGLITAZONE; GLITAZONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MELANOMA; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 33646093952     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200603000-00011     Document Type: Article

References (38)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29.
2. Eigentler TK, Caroli UM, Radny P, Garbe C. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol 2003; 4:748-759.
3. Hauschild A, Weichenthal M, Balda BR, Becker JC, Wolff HH, Tilgen W, et al. Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis. J Clin Oncol 2003; 21:2883-2888.
4. Kihara S, Ouchi N, Funahashi T, Shinohara E, Tamura R, Yamashita Y, et al. Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells. Atherosclerosis 1998; 136:163-168.
5. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339:953-959.
6. Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, et al. Ligand for peroxisome proliferator-activated receptor γ (Troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 1998; 58:3344-3352.
7. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, -γ in the adult rat. Endocrinology 1996; 137:354-366.
8. Lemberger T, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 1996; 12:335-363.
9. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, et al. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 1998; 95:8806-8811.
10. Sarraf P, Mueller E, Jones D, King FJ, De Angelo DJ, Partridge JB, et al. Differentation and reversal of malignant changes in colon cancer through PPAR γ. Nat Med 1998; 4:1046-1052.
11. Tsubouchi Y, Sano H, Kawahito Y, Mukai S, Yamada R, Kohno M, et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor γ agonists through induction of apoptosis. Biochem Biophys Res Commun 2000; 270:400-405.
12. Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, Kazumori H, et al. Expression of peroxisome proliferator-activated receptor (PPAR) γ in gastric cancer and inhibitory effects of PPARγ agonists. Br J Cancer 2000; 83:1394-1400.
13. Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y. Activation of peroxisome proliferator-activated receptor γ by Troglitazone inhibits cell growth through the increase of p27Kip1 in human pancreatic carcinoma cells. Cancer Res 2000; 60:5558-5564.
14. Guan YF, Zhang YH, Breyer RM, Davis L, Breyer MD. Expression of peroxisome proliferator-activated receptor γ (PPARγ) in human transitional bladder cancer and its role in inducing cell death. Neoplasia 1999; 1:330-339.
15. Rauth S, Green A, Kichima J, Shilkaitis A. Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53. Br J Cancer 1998; 77:2215-2222.
16. Edward M. Melanoma cell-derived factors stimulate glycosaminoglycan synthesis by fibroblast cultured as monolayers and within contracted collagen lattices. Br J Dermatol 2001; 144:465-470.
17. Carey TE, Takahashi T, Resnick LA, Oettgen HF, Old LJ. Cell surface antigens of human malignant melanoma; mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 1976; 73:3278-3282.
18. Fodstad O, Aamdal S, McMenamin M, Nesland JM, Phil A. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int J Cancer 1988; 41:442-449.
19. Fodstad O, Kjonniksen I, Aamdal S, Nesland JM, Boyd MR, Phil A. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res 1988; 48:4382-4388.
20. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 1995; 5:571-576.
21. Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purified components. Methods Enzymol 1983; 101:582-598.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 7:248-254.
23. Amiri KI, Horton LW, LaFleur BJ, Sosman JA, Richmond A. Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Res 2004; 64:4912-4918.
24. Kang HY, Chung E, Lee M, Cho Y, Kang WH. Expression and function of peroxisome proliferator-activated receptors in human melanocytes. Br J Dermatol 2004; 150:462-468.
25. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68:251-306.
26. Atallah E, Flaherty L. Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 2005; 6:185-193.
27. Placha W, Gil D, Dembinska-Kiec A, Laidler P. The effect of PPARγ ligands on the proliferation and apoptosis of human melanoma cells. Melanoma Res 2003; 13:447-456.
28. Matthaei S, Stumvoll M, Häring HU. Thiazolidinedione (Insulinsensitizer): Neue Aspekte in der terapie des Diabetes mellitus Typ 2. Dt Ärztebl 2001; 98:912-918.
29. Lucarelli E, Sangiogi L, Maini V, Lattanti G, Marmiroli S, Reggiani M, et al. Troglitazone affects survival of human osteosarcoma cells. Int J Cancer 2002; 89:344-351.
30. Min/+ mice. Nat Med 1998; 4:1053-1057.
31. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, et al. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 1998; 95:8806-8811.
32. Tsujie M, Nakamori S, Okami J, Hayashi N, Hiraoka N, Nagano H, et al. Thiazolidinediones inhibit growth of gastrointestinal, bilary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor γ/retinoid X receptor α pathway. Exp Cell Res 2003; 289:143-151.
33. Brockman JA, Gupta RA, Dubois RN. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 1998; 115:1049-1055.
34. 2, a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells. Biochem Biophys Res Commun 1999; 262:579-585.
35. Kitamura S, Miyazaki Y, Shinomura Y, Kondo S, Kanayama S, Matsuzawa Y. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res 1999; 90:75-80.
36. Thies A, Nugel D, Pfuller U, Moll I, Schumacher U. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro. Toxicology 2005; 207:105-116.
37. 2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase pathway. J Pharm Exp Ther 2003; 307:505-517.
38. Palakurthi SS, Aktas H, Grubissich LM, Mortensen RM, Halperin JA. Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediate by inhibition of translation initiation. Cancer Res 2001; 61:6213-6218.